XRCC5 and lung carcinoma: This result was consistent with a recent study showing that a novel antibody (7B7) directed against the Ku70/Ku80 heterodimer blocks invasion in pancreatic and lung cancer cells.12 Moreover, restoration of Ku80 could partially reverse the tumor metastasis inhibition induced by hsa-miR-623 in vitro.